PATENT CLAIM ANALYSIS

Application Number: 16155100
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "443000"]

Abstract:
The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent.

Claim (Index 5):
The composition of  claim 1 , wherein said chelator or antioxidant is selected from the group consisting of ethylenediaminetetraacetic acid (EDTA) and salts thereof, proteins, polysaccharides, polynucleic acids, glutamic acid, histidine, organic diacids, polypeptides, phytochelatin, hemoglobin, chlorophyll, humic acid, phosphonates, transferrin, desferrioxamine, dibutylhydroxytoluene (BHT), dibutylated hydroxyanisole (BHA), propyl gallate, sodium sulfate, citric acid, sodium metabisulfite, ascorbic acid, tocopherol, tocopherol ester derivatives, 2-mercaptob enzimidazoleand, and combinations thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.57447
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14196082', '12537571', '14989669', '15069875', '14390322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7686941678532729
- 35 USC 102 Novelty (BERT): 0.5562994833539883
- Combined Prediction Score: 0.7474546994033444
- Mean Citation Score: 354.520434
- Max Citation Score: 413.72986
- Similarity Product: 370.8405317860425

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test